Cargando…
Mesenchymal Stem Cell-Derived Exosomes as New Remedy for the Treatment of Neurocognitive Disorders
Mesenchymal stem cell (MSC)-derived exosomes (MSC-Exo) are nano-sized extracellular vesicles enriched with MSC-sourced neuroprotective and immunomodulatory microRNAs, neural growth factors, and anti-inflammatory cytokines, which attenuate neuro-inflammation, promote neo-vascularization, induce neuro...
Autores principales: | Harrell, Carl Randall, Volarevic, Ana, Djonov, Valentin, Volarevic, Vladislav |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7867043/ https://www.ncbi.nlm.nih.gov/pubmed/33535376 http://dx.doi.org/10.3390/ijms22031433 |
Ejemplares similares
-
Mesenchymal Stem Cell-Derived Exosomes and Other Extracellular Vesicles as New Remedies in the Therapy of Inflammatory Diseases
por: Harrell, Carl Randall, et al.
Publicado: (2019) -
Therapeutic Potential of Exosomes Derived from Adipose Tissue-Sourced Mesenchymal Stem Cells in the Treatment of Neural and Retinal Diseases
por: Harrell, Carl Randall, et al.
Publicado: (2022) -
Therapeutic Use of Mesenchymal Stem Cell-Derived Exosomes: From Basic Science to Clinics
por: Harrell, Carl Randall, et al.
Publicado: (2020) -
NLRP3 Inflammasome as a Potentially New Therapeutic Target of Mesenchymal Stem Cells and Their Exosomes in the Treatment of Inflammatory Eye Diseases
por: Harrell, Carl Randall, et al.
Publicado: (2023) -
Therapeutic Potential of Mesenchymal Stem Cells in the Treatment of Ocular Graft-Versus-Host Disease
por: Harrell, Carl Randall, et al.
Publicado: (2022)